[68Ga]Ga-ABY-025
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for [68Ga]Ga-ABY-025, covering 2022-11-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy [EARLY_Phase 1]